Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus × O. aureus) with an inactivated Vibrio vulnificus vaccine

Biologicals

Volumn 39, Issue 6, 2011, Pages 424-429

  Shoemaker, Craig A ^a   LaFrentz, Benjamin R ^a   Klesius, Phillip H ^a  

^a AQUATIC ANIMAL HEALTH RESEARCH UNIT   (United States)

Author keywords

Aquaculture; Tilapia; Vaccine; Vibrio vulnificus

Indexed keywords

ADJUVANT; BACTERIAL VACCINE; INACTIVATED VACCINE; MINERAL OIL; RNA 16S; RNA 16S TYPE B; SALT WATER; UNCLASSIFIED DRUG; VCG TYPE C; VIBRIO VULNIFICUS VACCINE; VVHA TYPE 2; WATER;

ANTIBODY TITER; ARTICLE; BACTERIUM ISOLATION; BIOCHEMISTRY; BIOTYPE; CONTROLLED STUDY; FEMALE; HYBRID; MALE; MOLECULAR BIOLOGY; NONHUMAN; OREOCHROMIS AUREUS; OREOCHROMIS NILOTICUS; PRIORITY JOURNAL; SEX TRANSFORMATION; SURVIVAL; TILAPIA; VACCINATION; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS INFECTION; VIRUS INFECTIVITY; WHOLE CELL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CICHLIDS; FEMALE; FISH DISEASES; HUMANS; HYBRIDIZATION, GENETIC; MALE; RNA, RIBOSOMAL, 16S; SURVIVAL ANALYSIS; SURVIVAL RATE; TILAPIA; TIME FACTORS; VACCINATION; VACCINES, INACTIVATED; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

OREOCHROMIS NILOTICUS; TILAPIA; VIBRIO VULNIFICUS;

EID: 80055036963     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.08.004     Document Type: Article

References (30)

1. Strom M.S., Paranjpye R.N. Epidemiology and pathogenesis of Vibrio vulnificus. Microb Infect 2000, 2:177-188.
2. Jones M.K., Oliver J.D. Vibrio vulnificus: disease and pathogenesis. Infect Immun 2009, 77:1723-1733.
3. Austin B. Vibrios as causal agents of zoonoses. Vet Microbiol 2010, 140:310-317.
4. Fouz B., Larsen J.L., Amaro C. Vibrio vulnificus serovar A: an emerging pathogen in European anguilliculture. J Fish Dis 2006, 29:285-291.
5. Tison D.L., Nishibuchi M., Greenwood J.D., Seidler R.J. Vibrio vulnificus biogroup 2: new biogroup pathogenic for eels. Appl Environ Microbiol 1982, 44:640-646.
6. Li G., Zhao D., Huang L., Sun J., Gao D., Wang H., et al. Identification and phylogenetic analysis of Vibrio vulnificus isolated from diseased Trachinotus ovatus in cage mariculture. Aquaculture 2006, 261:17-25.
7. Sakata T., Hattori M. Characteristics of Vibrio vulnificus isolated from diseased tilapia. Fish Pathol 1988, 23:33-40.
8. Chen C.-Y., Chao C.-B., Bowser P.R. Infection of tilapia Oreochromis sp. by Vibrio vulnificus in freshwater and low-salinity environments. J World Aquacult Soc 2006, 37:82-88.
9. Pederson K., Skall H.F., Lassen-Nielson A.M., Nielson T.F., Henriksen N.H., Olesen N.J. Surveillance of health status on eight marine rainbow trout, Oncorhynchus mykiss (Walbaum), farms in Denmark in 2006. J Fish Dis 2008, 31:659-667.
10. Biosca E.G., Amaro C. Toxic and enzymatic activities of Vibrio vulnificus biotype 2 with respect to host specificity. Appl Environ Microbiol 1996, 62:2331-2337.
11. Fouz B., Alcaide E., Barrera R., Amaro C. Susceptibility of Nile tilapia (Oreochromis niloticus) to vibriosis due to Vibrio vulnificus biotype 2 (serovar E). Aquaculture 2002, 212:21-30.
12. Mladineo I., Miletic I. Rearing and diseases of Northern Atlantic bluefin tuna (Thunnus thynnus) in the Adriatic Sea. World Aquacult Mag 2008, 39:26-29.
13. Mahmud Z.H., Wright A.C., Mandal S.C., Dai J., Jones M.K., Hasan M., et al. Genetic characterization of Vibrio vulnificus strains from tilapia aquaculture in Bangladesh. Appl Environ Microbiol 2010, 76:4890-4895.
14. Sanjuán E., Fouz B., Oliver J.D., Amaro C. Evaluation of genotypic and phenotypic methods to distinguish clinical from environmental Vibrio vulnificus strains. Appl Environ Microbiol 2009, 75:1604-1613.
15. Fouz B., Llorens A., Valiente E., Amaro C. A comparative epizootiologic study of the two fish-pathogenic serovars of Vibrio vulnificus biotype 2. J Fish Dis 2010, 33:383-390.
16. Aznar R., Ludwig W., Amann R.I., Schleifer K.H. Sequence determination of rRNA genes of pathogenic Vibrio species and whole-cell identification of Vibrio vulnificus with rRNA-targeted oligonucleotide probes. Int J Syst Bacteriol 1994, 44:330-337.
17. Nilsson W.B., Paranjpye R.N., DePaola A., Strom M.S. Sequence polymorphism of the 16S rRNA gene of Vibrio vulnificus is a possible indicator of strain virulence. J Clin Microbiol 2003, 41:442-446.
18. Senoh M., Miyoshi S., Okamoto K., Fouz B., Amaro C. The cytotoxin-hemolysin genes of human and eel pathogenic Vibrio vulnificus strains: comparison of nucleotide sequences and application to the genetic grouping. Microbiol Immunol 2005, 45:513-519.
19. Rosche T.M., Yano Y., Oliver J.D. A rapid and simple PCR analysis indicates there are two subgroups of Vibrio vulnificus which correlate with clinical or environmental isolation. Microbiol Immunol 2005, 49:381-389.
20. Warner E.B., Oliver J.D. Multiplex PCR assay for detection and simultaneous differentiation of genotypes of Vibrio vulnificus biotype 1. Foodborne Pathog Dis 2008, 5:691-693.
21. Shoemaker C.A., Arias C.R., Klesius P.H., Welker T.L. Technique for identifying Flavobacterium columnare using whole cell fatty acid profiles. J Aquat Anim Health 2005, 17:267-274.
22. Avaniss-Aghajani E., Jones K., Holtzman A., Aronson T., Glover N., Boian M., et al. Molecular technique for rapid identification of mycobacteria. J Clin Microbiol 1996, 34:98-102.
23. Klesius P.H., Shoemaker C.A., Evans J.J. Efficacy of single and combined Streptococcus iniae isolate vaccine administered by intraperitoneal and intramuscular routes in tilapia (Oreochromis niloticus). Aquaculture 2000, 188:237-246.
24. MIDI Inc Sherlock microbial identification system rapid methods user's guide, version 5.0 2002, MIDI, Inc, Newark, Delaware.
25. Collado R., Fouz B., Sanjuan E., Amaro C. Effectiveness of different vaccine formulations against vibriosis cause by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla. Dis Aquat Org 2000, 43:91-101.
26. Esteve-Gassent M.D., Nielsen M.E., Amaro C. The kinetics of antibody production in mucus and serum of European eel (Anguilla anguilla L.) after vaccination against Vibrio vulnificus: development of a new method for antibody quantification in skin mucus. Fish Shellfish Immunol 2003, 15:51-61.
27. Esteve-Gassent M.D., Fouz B., Amaro C. Efficacy of a bivalent vaccine against eel diseases caused by Vibrio vulnificus after its administration by four different routes. Fish Shellfish Immunol 2004, 16:93-105.
28. Park J.-H., Park W.J., Jeong H.D. Immunological efficacy of Vibrio vulnificus bacterins given as an oral vaccine in the flounder, Paralichthys olivaceus. Aquaculture 2001, 201:187-197.
29. Biosca E.G., Oliver J.D., Amaro C. Phenotypic characterization of Vibrio vulnificus biotype 2, a lipopolysaccharide-based homogenous O serogroup within Vibrio vulnificus. Appl Environ Microbiol 1996, 62:918-927.
30. Bisharat N., Agmon V., Finkelstein R., Raz R., Ben-Dror G., Lerner L., et al. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Lancet 1999, 354:1421-1424.